• About
  • Advertise
  • Privacy & Policy
  • Contact
HK Businesswire
  • Home
  • News
    • All
    • Business
    • Politics
    • PR Newswire
    • Science
    • World
    Xia Baolong concludes HK inspection

    Xia Baolong concludes HK inspection

    Iran deal ‘not final’, says Trump

    Seven Perfect Shuffles Randomize a Deck of Cards. But How Many Sloppy Ones?

    AXI SECURES FSC MAURITIUS LICENCE, BRINGING REGULATED TRADING TO THE WORLD’S FASTEST-GROWING MARKETS

    AXI SECURES FSC MAURITIUS LICENCE, BRINGING REGULATED TRADING TO THE WORLD’S FASTEST-GROWING MARKETS

    CE welcomes Hainan Governor

    CE welcomes Hainan Governor

    Man vs. Machine: 7th-Gen COFE+ Robotic Café Outperforms Elite Baristas in Historic Live Showdown

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • PR Newswire
  • Business
  • World
  • Entertainment
  • Sports
  • Tech
    • All
    • Apps
    • Gadget
    • Mobile
    • Startup

    Alipay Launches AI-Powered Version ‘Abao’ to Streamline Services

    Xiaohongshu Prepares Confidential Hong Kong IPO Filing

    SpaceX Raises $75 Billion in Historic IPO Amid $350 Billion Investor Demand

    Chinese firms double down on tech: Xiaomi, Haier

    Xiaomi Launches MiMo Code AI Programming Assistant to Enter Coding Agent Market

    Apple Unveils Overhauled Siri AI and Major OS Updates at WWDC 2026

    OpenAI launches AI browser Atlas

    OpenAI Files Confidentially for IPO Amid Intensifying AI Competition

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
  • Feature
No Result
View All Result
  • Home
  • News
    • All
    • Business
    • Politics
    • PR Newswire
    • Science
    • World
    Xia Baolong concludes HK inspection

    Xia Baolong concludes HK inspection

    Iran deal ‘not final’, says Trump

    Seven Perfect Shuffles Randomize a Deck of Cards. But How Many Sloppy Ones?

    AXI SECURES FSC MAURITIUS LICENCE, BRINGING REGULATED TRADING TO THE WORLD’S FASTEST-GROWING MARKETS

    AXI SECURES FSC MAURITIUS LICENCE, BRINGING REGULATED TRADING TO THE WORLD’S FASTEST-GROWING MARKETS

    CE welcomes Hainan Governor

    CE welcomes Hainan Governor

    Man vs. Machine: 7th-Gen COFE+ Robotic Café Outperforms Elite Baristas in Historic Live Showdown

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • PR Newswire
  • Business
  • World
  • Entertainment
  • Sports
  • Tech
    • All
    • Apps
    • Gadget
    • Mobile
    • Startup

    Alipay Launches AI-Powered Version ‘Abao’ to Streamline Services

    Xiaohongshu Prepares Confidential Hong Kong IPO Filing

    SpaceX Raises $75 Billion in Historic IPO Amid $350 Billion Investor Demand

    Chinese firms double down on tech: Xiaomi, Haier

    Xiaomi Launches MiMo Code AI Programming Assistant to Enter Coding Agent Market

    Apple Unveils Overhauled Siri AI and Major OS Updates at WWDC 2026

    OpenAI launches AI browser Atlas

    OpenAI Files Confidentially for IPO Amid Intensifying AI Competition

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
  • Feature
No Result
View All Result
HK Businesswire
No Result
View All Result
Home News Business

StanChart pre-tax profit up 16pc in 2025

Xenia. W by Xenia. W
24 February 2026
in Business, News
0
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter
Standard Chartered on Tuesday reported that its pre-tax profit for 2025 climbed 16 percent year on year to US$6.96 billion, as robust global banking and strong wealth inflows boosted revenue.

The lender, which earns most of its revenue in Asia and Africa, also saw its full-year operating income grow by seven percent year on year to US$20.9 billion.

Profits picked up in the final quarter, rising by two percent year on year to US$814 million, though that was lower than analysts’ expectations of US$1.06 billion.

The full-year pre-tax profits also missed the US$7.2 billion average of 16 analyst estimates compiled by the lender.

In a statement, chief executive Bill Winters said the bank saw strong momentum last year, with its adjusted return on tangible equity, a gauge of profitability, hitting 14.7 percent for the full year, exceeding its 13 percent target.

“We have made a good start to the year and continue to benefit from a supportive business environment,” he said.

“We are seeing robust growth in our larger markets, and structural shifts in global trade and investment play to our distinctive strengths serving our clients’ cross-border and affluent banking needs.”

The emerging market-focused lender proposed a final dividend of 49 US cents per share, bringing the full-year total to 61 US cents per share, up by 65 percent from a year earlier.

The bank also announced it was launching a new share buyback of US$1.5 billion, which it said would be “commenced imminently”.

Looking ahead, it said it sees reported operating income growth year on year to be around the bottom end of five to seven percent range at constant currency. (Additional reporting by Reuters)

Edited by Thomas McAlinden

Tags: BusinessFinance
Xenia. W

Xenia. W

Xenia is a Hong Kong–based writer and content creator focusing on financial markets, policy and the city’s evolving economic landscape. With over ten years of experience in higher education and tourism‑related projects, she specialises in transforming complex information into clear, reader‑friendly insights for both professional and general audiences. ​ Drawing on a background in bilingual Chinese–English translation and editing, Xenia writes across topics including Hong Kong and US stocks, market structure, macro trends and how policy shifts affect everyday investors.

Read More

Antengene Announces Exclusive License Agreement with MPM BioImpact-Established K2 Therapeutics for ATG-106 and Option for Undisclosed Bispecific TCE

Antengene Announces Exclusive License Agreement with MPM BioImpact-Established K2 Therapeutics for ATG-106 and Option for Undisclosed Bispecific TCE

22 June 2026

Innovent Biologics Announces First Patient Dosed in a Phase 3 Clinical Trial of IBI3003(GPRC5D/BCMA/CD3 Tri-specific Antibody) for the Treatment of Multiple Myeloma

22 June 2026
  • Trending
  • Comments
  • Latest
Clarivate Releases Journal Citation Reports 2026

Clarivate Releases Journal Citation Reports 2026

17 June 2026

HKICPA Supports Government Plan to Boost Corporate Treasury Centres in Hong Kong

12 June 2026
Jabs urged as doctors fear flu season overlap

Ping An Good Doctor Upgrades AI Health Service to Cover 90 Million Monthly Users

17 June 2026

Fluorescent nanosensor enables rapid, first-of-its-kind detection of key gut health biomarker

15 June 2026
Xia Baolong concludes HK inspection

Xia Baolong concludes HK inspection

17 June 2026

Iran deal ‘not final’, says Trump

17 June 2026

Seven Perfect Shuffles Randomize a Deck of Cards. But How Many Sloppy Ones?

17 June 2026
AXI SECURES FSC MAURITIUS LICENCE, BRINGING REGULATED TRADING TO THE WORLD’S FASTEST-GROWING MARKETS

AXI SECURES FSC MAURITIUS LICENCE, BRINGING REGULATED TRADING TO THE WORLD’S FASTEST-GROWING MARKETS

17 June 2026

Recent News

Xia Baolong concludes HK inspection

Xia Baolong concludes HK inspection

17 June 2026

Iran deal ‘not final’, says Trump

17 June 2026

Seven Perfect Shuffles Randomize a Deck of Cards. But How Many Sloppy Ones?

17 June 2026
AXI SECURES FSC MAURITIUS LICENCE, BRINGING REGULATED TRADING TO THE WORLD’S FASTEST-GROWING MARKETS

AXI SECURES FSC MAURITIUS LICENCE, BRINGING REGULATED TRADING TO THE WORLD’S FASTEST-GROWING MARKETS

17 June 2026
HK Businesswire

Stay ahead with the latest insights on Hong Kong’s economy, finance, and investments. From market trends to policy updates, we bring you in-depth analysis and expert opinions.

📩 Subscribe to our newsletter for exclusive updates.
📍 Follow us on social media for real-time news.
📧 Contact us: info@hongkong-invest.com

Follow Us

  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2025 by HKBusinesswire.com

No Result
View All Result

© 2025 by HKBusinesswire.com